A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Prostate cancer usually develops slowly, so there may be no signs of the health condition for many years, but once the tumour ...

Over the coming months, it is anticipated Pluvicto will be available for eligible patients at most of Ontario’s Cancer ...

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.